Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31100605 | 0.83 | CRBN (0.45) | CRBNDDB1 | |
| SCHEMBL32660422 | 0.83 | CRBN (0.38) | CRBNDDB1 | |
| SCHEMBL31100634 | 0.81 | CRBN (0.45) | CRBNDDB1 | |
| SCHEMBL31103000 | 0.81 | CRBN (0.45) | CRBNDDB1 | |
| SCHEMBL31101169 | 0.81 | CRBN (0.47) | CRBNDDB1 | |
| SCHEMBL31099845 | 0.79 | CRBN (0.42) | CRBNDDB1 | |
| SCHEMBL32660350 | 0.79 | CRBN (0.36) | CRBNDDB1 | |
| SCHEMBL32660445 | 0.78 | CRBN (0.38) | CRBNDDB1 | |
| SCHEMBL32660594 | 0.78 | CRBN (0.45) | CRBNDDB1 | |
| SCHEMBL32660643 | 0.77 | CRBN (0.37) | CRBNDDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678638-A1 | NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-01-14 | — | — | EP | claimed |
| EP-4678638-A1 | NEW E3 UBIQUITIN LIGASE LIGAND, PROTEIN DEGRADATION AGENT AND USE THEREOF | Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) | 2026-01-14 | — | — | EP | disclosed |